MERO, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.025
AS - Asia 1.558
EU - Europa 912
SA - Sud America 360
AF - Africa 332
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 15
Totale 7.236
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.856
SG - Singapore 557
CN - Cina 285
BR - Brasile 233
VN - Vietnam 189
IT - Italia 181
HK - Hong Kong 152
DE - Germania 98
FI - Finlandia 93
UA - Ucraina 50
FR - Francia 45
GB - Regno Unito 45
RU - Federazione Russa 43
SE - Svezia 40
PL - Polonia 28
AR - Argentina 24
EC - Ecuador 23
TR - Turchia 22
ID - Indonesia 20
MX - Messico 20
NL - Olanda 20
AE - Emirati Arabi Uniti 19
CA - Canada 17
CO - Colombia 16
IE - Irlanda 16
IN - India 16
IS - Islanda 15
VE - Venezuela 15
ZA - Sudafrica 15
BJ - Benin 14
ES - Italia 14
IQ - Iraq 14
JP - Giappone 14
MY - Malesia 14
RE - Reunion 14
KR - Corea 13
UZ - Uzbekistan 13
AT - Austria 12
AZ - Azerbaigian 12
BY - Bielorussia 12
ET - Etiopia 12
GM - Gambi 12
HN - Honduras 12
IL - Israele 12
KE - Kenya 12
PS - Palestinian Territory 12
SI - Slovenia 12
SK - Slovacchia (Repubblica Slovacca) 12
BA - Bosnia-Erzegovina 11
BD - Bangladesh 11
BO - Bolivia 11
CH - Svizzera 11
DO - Repubblica Dominicana 11
DZ - Algeria 11
HR - Croazia 11
JO - Giordania 11
MZ - Mozambico 11
NP - Nepal 11
PY - Paraguay 11
RW - Ruanda 11
SA - Arabia Saudita 11
TN - Tunisia 11
UG - Uganda 11
YE - Yemen 11
AF - Afghanistan, Repubblica islamica di 10
BE - Belgio 10
BF - Burkina Faso 10
IR - Iran 10
KH - Cambogia 10
LV - Lettonia 10
MK - Macedonia 10
MU - Mauritius 10
NZ - Nuova Zelanda 10
PE - Perù 10
PH - Filippine 10
PK - Pakistan 10
PR - Porto Rico 10
TH - Thailandia 10
TT - Trinidad e Tobago 10
XK - ???statistics.table.value.countryCode.XK??? 10
AD - Andorra 9
AL - Albania 9
AM - Armenia 9
BB - Barbados 9
BG - Bulgaria 9
CU - Cuba 9
CY - Cipro 9
CZ - Repubblica Ceca 9
DK - Danimarca 9
EE - Estonia 9
GF - Guiana Francese 9
MA - Marocco 9
ML - Mali 9
MR - Mauritania 9
NC - Nuova Caledonia 9
PT - Portogallo 9
RO - Romania 9
TZ - Tanzania 9
YT - Mayotte 9
CR - Costa Rica 8
Totale 6.910
Salva come PNG Salva come JPEG
Città #
Fairfield 492
Woodbridge 398
Houston 392
Ann Arbor 345
Ashburn 321
Singapore 261
Seattle 206
Wilmington 198
Chandler 196
Jacksonville 195
Cambridge 157
Hong Kong 147
Santa Clara 98
Boardman 78
Dong Ket 78
Beijing 76
Princeton 68
Padova 57
Roxbury 47
Medford 41
Nanjing 40
Munich 35
San Diego 34
Ho Chi Minh City 32
Buffalo 29
Helsinki 29
Des Moines 26
Hanoi 26
Los Angeles 25
Guangzhou 24
Mestre 24
Bytom 20
Venice 19
São Paulo 17
Milan 15
Redondo Beach 15
Cotonou 13
Reykjavik 12
Tashkent 12
Amman 11
Dublin 11
Kampala 11
Kigali 11
London 11
Nairobi 11
Baku 10
Cardiff 10
Chicago 10
Maputo 10
New York 10
Phnom Penh 10
Riga 10
Turku 10
Vienna 10
Addis Ababa 9
Andorra la Vella 9
Hefei 9
Noumea 9
Yerevan 9
Abu Dhabi 8
Bamako 8
Banjul 8
Brooklyn 8
Dar es Salaam 8
Dili 8
Ljubljana 8
Managua 8
Nouakchott 8
Ouagadougou 8
Podgorica 8
Praia 8
Quito 8
San José 8
Accra 7
Amsterdam 7
Auckland 7
Bridgetown 7
Castries 7
Cayenne 7
Falls Church 7
Guayaquil 7
Havana 7
Istanbul 7
Lusaka 7
Minsk 7
Rio de Janeiro 7
San Francisco 7
Sanaa 7
Shenyang 7
Tallinn 7
Tel Aviv 7
Tianjin 7
Ulan Bator 7
Vientiane 7
Belo Horizonte 6
Dakar 6
Dallas 6
Haiphong 6
Harare 6
Jiaxing 6
Totale 4.794
Salva come PNG Salva come JPEG
Nome #
Transgultaminase-Mediated Nanoarmoring of Enzymes by PEGylation 250
Site-selective enzymatic chemistry for polymer conjugation to protein lysine residues: PEGylation of G-CSF at lysine-41 246
Site-Specific Transglutaminase-Mediated Conjugation of Interferon α-2b at Glutamine or Lysine Residues 239
Chemical and Enzymatic Site Specific PEGylation of hGH: The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates 226
Hyaluronic acid as a protein polymeric carrier: An overview and a report on human growth hormone 218
Drug and protein delivery by polymer conjugation 218
Chemical and Enzymatic Site Specific PEGylation of hGH 203
A new method to increase selectivity of transglutaminase mediated PEGylation of salmon calcitonin and human growth hormone 200
A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer 194
Dendritic Poly(ethylene glycol) Bearing Paclitaxel and Alendronate for Targeting Bone Neoplasms 191
Covalent conjugation of poly(ethylene glycol) to proteins and peptides: strategies and methods 191
Covalent immobilisation of transglutaminase: stability and applications in protein PEGylation 187
Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy. 174
Multivalent and Flexible PEG-Nitrilotriacetic Acid Derivatives for Non-covalent Protein Pegylation 173
A Biodegradable Polymeric Carrier Based on PEG for Drug Delivery 173
A new PEG-b-alanine active derivative for releasable protein conjugation 172
Conjugation of hyaluronan to proteins 168
Inulin-d-α-Tocopherol Succinate (INVITE) Nanomicelles as a Platform for Effective Intravenous Administration of Curcumin 167
Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase 159
Polyoxazoline: chemistry, properties, and applications in drug delivery 153
Transglutaminase-mediated PEGylation of proteins: direct identification of the sites of protein modification by mass spectrometry using a novel monodisperse PEG 152
Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor 146
PHEA-Graft-Polymethacrylate Supramolecular Aggregates for Protein Oral Delivery 146
The Site-specific TGase-mediated PEGylation of Proteins Occurs at Flexible Sites 137
A hyaluronic acid-salmon calcitonin conjugate for the local treatment of osteoarthritis: Chondro-protective effect in a rabbit model of early OA 136
Development of a new hyaluronic acid-calcitonin conjugate for the local treatment of osteoarthritis 136
Synthesis and characterization of poly(2-ethyl 2 oxazoline)-conjugates with proteins and drugs: suitable alternatives to PEG-conjugates? 128
Farmacodinamica dei farmaci biologici 127
Site-Specific Pegylation of G-CSF by Reversible Denaturation 126
Recent Developments in Hyaluronic Acid-Based Nanomedicine 126
Protein PEGylation, basic science and biological applications 123
PEG: an useful technology in anticancer therapy 123
A new method for high selective TGase-mediated PEGylation of salmon calcitonin and human growth hormone 122
Polymer-Drug Conjugates for Combination Anticancer Therapy: Investigating the Mechanism of Action 118
Development of a novel HA-activated derivative for protein delivery. 113
A new high loading PEG fro drug release 110
A novel PEG-chelating agent conjugate for protein delivery 109
Novel PEG conjugates releasing nitric oxide: preparation and activity against oxidative stress in ischemia reperfusion injury 101
hGH-PEG-betaAla coniugate releasing the native protein: pharmacokinetic evaluation in monkeys and activity investigation in hypophysectomized rats. 101
Polyethylene glycol (PEG)-dendron phospholipids as innovative pharmaceutical products to make super stealth liposomes for anticancer therapy 100
Identification by mass spectrometry of the sites of protein PEGylation by TGase using a novel monodisperse PEG 95
Hyaluronic acid as platform for the delivery of biologics for osteoarthritis treatment 89
Comparison of two different site-specific conjugates of hGH in biophysical and in vivo studies. 89
Poly(ethylene glycol)-mesalazine conjugate for colon specific release 88
Intra-Articular injection of a Hyaluronic acid - Salmon Calcitonin Conjugate as Potential Treatment of Osteoarthritis 80
Poly(2-ethyl 2-oxazoline): a promising polymer for protein conjugation 75
Metodo per la preparazione di coniugati mediante transglutaminasi 72
New startegies in PEG protein modification: the salmon calcitonin (sCT) case 69
Combination therapy: the case of NO-PEGylated epirubicin. 66
PEGylation of peptide-triazole retained dual-antagonist towards HIV-1 entry and improved pharmacokinetic 63
Poly(2-ethyl 2-oxazoline): a novel polymer for protein and drug conjugation 55
In vivo evaluation of a hyaluronic acid-salmon calcitonin conjugate for the treatment of osteoarthritis 39
Totale 7.262
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.802
article - articoli 13.803
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 226
selected - selezionate 0
volume - volumi 2.955
Totale 38.786
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021556 0 0 0 0 19 44 16 67 98 101 111 100
2021/2022627 15 75 108 36 32 20 21 84 21 6 71 138
2022/2023441 100 14 8 30 100 63 5 35 50 3 23 10
2023/2024241 23 29 21 19 16 4 7 22 18 29 32 21
2024/20251.057 3 34 70 39 183 27 44 100 90 39 190 238
2025/20262.172 162 407 613 705 285 0 0 0 0 0 0 0
Totale 7.262